A Phase I Study to Assess the Safety and Immunogenicity of ChAd63 ME-TRAP - MVA ME-TRAP Heterologous Prime-boost Vaccination Co-administered With EPI Vaccines in Gambian Infants

NCT02083887 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
65
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

University of Oxford

Collaborators